Director, Real World Value and Evidence - Hematology Oncology
- Horsham, PA
- Permanent
- Full-time
- Lead a team of Associate Directors to deliver on RWV&E stakeholder commitments by providing a stable and inclusive environment
- Ensure real world evidence and market access scientific support requirements are understood and built-in to the US business plans with value propositions that reflect the needs of key payer stakeholders, population health decision makers and lead scientific strategic planning for RWV&E activities to enable access.
- RWV&E activities this role is held accountable for include but are not limited to: formulating key research questions, identifying key analytical questions to shape evidence generation strategy, designing and conducting studies, planning and conducting market access analytics, managing publications, developing communication materials (e.g., Evidence & Access decks), and partnering with MSL/RWV&E FIELD to ensure effective and compliant communication.
- Ensures projects are aligned to the Integrated Evidence Generation Plan (IEGP) and business needs and executed on time
- Collaborate with internal and external experts to prioritize and generate rigorous scientific data, and develop dissemination plans to support the therapeutic area's IEGP
- Ensures compliance with regulatory, legal and commercial regulations (for example Contract Pricing Committee, Copy Approval Committee) in conducting research and dissemination of scientific information
- Collaborate with cross-functional business partners and alliance partners on scientific strategies to support market access for our products
- Directly initiate and manage research studies and other related projects
- Serve as subject matter, and functional area expert in responding to U.S-focused Health Technology/Value Assessments of our products by external organizations
- Ensure quality of design, execution, and publication of real-world evidence studies, and quality of models & tools developed for business partners
- Develop annual business plan budget, present to appropriate levels of management for approval, and manage budgeted funds appropriately
- Ensure quality in internal / external communications including: publications, training support of RWVE studies, and models and/or tools developed for the therapeutic area.
- Serve as a leader on assigned cross-functional franchise teams, with internal partners such as Scientific Affairs, Marketing, Medical Affairs, Strategic Customer Group, GCSO, Epidemiology, Government Affairs and Policy, others as needed.
- A minimum of a Master's degree in Public Health, Health Services Research, Economics, Epidemiology, Pharmacy, Health Policy, or a related discipline is required; A doctorate or other advanced degree is preferred.
- A minimum of 8 or more years of relevant research experience.
- Expertise in the healthcare industry, clinical knowledge or practice across multiple therapeutic areas, medical reimbursement, technical expertise in economic evaluations or patient-reported outcomes, including data analysis and statistics.
- Excellent in leadership skills, collaboration, influencing and communication (both written and presentation).
- Serve as a leader on the assigned cross-functional franchise teams pertaining to observational data or research, market access scientific strategy, payer insights/ data needs, etc.
- Experience in communicating technical data both internally and externally to non-technical audiences.
- Independent high- level planning and execution of research strategies.
- Solid experience in conducting Real World Evidence studies applying health economics, patient-reported outcomes, retrospective data analyses, epidemiology or health services research.
- Firm understanding of drug development process including health economic inputs needed to support the value proposition.
- Firm understanding of regulatory standards for approval and communication of data.
- Firm understanding of United States health care systems and customers; specifically understanding unique business models and perspectives.
- Firm understanding of the uses of evidence-based medicine and comparative effectiveness analyses for health policy decision-making.
- Up to 30% travel required mostly national with occasional international travel.
- Hematology-Oncology real-world evidence generation experience is preferred
- Experience in developing and gaining management approval for value-based scientific strategies and tactics to meet both commercial and scientific objectives for a given product or therapeutic area is preferred